prednisolone has been researched along with Gray Platelet Syndrome in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Gray Platelet Syndrome: A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuno, N | 1 |
| Kanamori, E | 1 |
| Saito, H | 1 |
| Murakami, N | 1 |
| Tojo, N | 1 |
| Tohda, S | 1 |
1 other study available for prednisolone and Gray Platelet Syndrome
| Article | Year |
|---|---|
A case of gray platelet syndrome masked by immune thrombocytopenia at presentation.
Topics: Antigens, Human Platelet; Blood Platelets; Cytoplasmic Granules; Delayed Diagnosis; Epstein-Barr Vir | 2014 |